Mr. Johnson has played key roles in several top tier biotechnology
companies prior to joining DDR. At Transkaryotic Therapies,
Mr. Johnson managed the clinical supply operations and the planning
and startup of the Replagal® commercial supply chain. His
experiences at Biogen spanned from manufacturing and technology transfer
to clinical and commercial supply operations planning and analysis
(Amevive® and Avonex®). His experience in quality assurance
and quality control at Genetics Institute and Genzyme Tissue Repair
round out his capabilities to provide a highly complementary skill
set to support any operations initiative.
Mr. Johnson has earned a MBA from Boston University and a BS in
Biotechnology from Worcester Polytechnic Institute. |